시장조사 보고서 : 세계의 전이성 암 치료 시장예측 2021년-2026년

■ 영문 제목 : Global Metastatic Cancer Treatment Market Growth (Status and Outlook) 2021-2026
	■ 상품코드 : LPI-2201K02228 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 100 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦4,941,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,411,500	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦9,882,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 전이성 암 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (화학 치료, 방사선 치료, 생물학적 표적 치료, 호르몬 치료)와 용도별 시장규모 (병원, 진료소, 기타) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 전이성 암 치료 시장 점유율
- 지역별 전이성 암 치료 시장규모
- 주요지역의 종류별 시장규모 (화학 치료, 방사선 치료, 생물학적 표적 치료, 호르몬 치료)
- 주요지역의 용도별 시장규모 (병원, 진료소, 기타)
- 미주의 전이성 암 치료 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 전이성 암 치료 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 전이성 암 치료 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 전이성 암 치료 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 전이성 암 치료 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Roche, Novartis, Merck, Eli Lilly, Johnson & Johnson, Pfizer, AstraZeneca, GlaxoSmithKline, Sun Pharmaceutical, Bayer, Gilead Sciences
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Metastatic Cancer Treatment will have significant change from previous year. By the most conservative estimates of global Metastatic Cancer Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 49140 million in 2020. Over the next five years the Metastatic Cancer Treatment market will register a 4.6% CAGR in terms of revenue, the global market size will reach US$ 58720 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Metastatic Cancer Treatment market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Chemotherapy
Radiation Therapy
Biologic Targeted Therapy
Hormone Therapy

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Hospitals
Clinics
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Roche
Novartis
Merck
Eli Lilly
Johnson & Johnson
Pfizer
AstraZeneca
GlaxoSmithKline
Sun Pharmaceutical
Bayer
Gilead Sciences

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Metastatic Cancer Treatment Market Size 2016-2026
2.1.2 Metastatic Cancer Treatment Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Metastatic Cancer Treatment Segment by Type
2.2.1 Chemotherapy
2.2.2 Chemotherapy
2.2.3 Biologic Targeted Therapy
2.2.4 Hormone Therapy
2.3 Metastatic Cancer Treatment Market Size by Type
2.3.1 Global Metastatic Cancer Treatment Market Size CAGR by Type
2.3.2 Global Metastatic Cancer Treatment Market Size Market Share by Type (2016-2021)
2.4 Metastatic Cancer Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Other
2.5 Metastatic Cancer Treatment Market Size by Application
2.5.1 Global Metastatic Cancer Treatment Market Size CAGR by Application
2.5.2 Global Metastatic Cancer Treatment Market Size Market Share by Application (2016-2021)

3 Metastatic Cancer Treatment Market Size by Players
3.1 Metastatic Cancer Treatment Market Size Market Share by Players
3.1.1 Global Metastatic Cancer Treatment Revenue by Players (2019-2021E)
3.1.2 Global Metastatic Cancer Treatment Revenue Market Share by Players (2019-2021E)
3.2 Global Metastatic Cancer Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Metastatic Cancer Treatment by Regions
4.1 Metastatic Cancer Treatment Market Size by Regions (2016-2021)
4.2 Americas Metastatic Cancer Treatment Market Size Growth (2016-2021)
4.3 APAC Metastatic Cancer Treatment Market Size Growth (2016-2021)
4.4 Europe Metastatic Cancer Treatment Market Size Growth (2016-2021)
4.5 Middle East & Africa Metastatic Cancer Treatment Market Size Growth (2016-2021)

5 Americas
5.1 Americas Metastatic Cancer Treatment Market Size by Country (2016-2021)
5.2 Americas Metastatic Cancer Treatment Market Size by Type (2016-2021)
5.3 Americas Metastatic Cancer Treatment Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Metastatic Cancer Treatment Market Size by Region (2016-2021)
6.2 APAC Metastatic Cancer Treatment Market Size by Type (2016-2021)
6.3 APAC Metastatic Cancer Treatment Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Metastatic Cancer Treatment by Country (2016-2021)
7.2 Europe Metastatic Cancer Treatment Market Size by Type (2016-2021)
7.3 Europe Metastatic Cancer Treatment Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Metastatic Cancer Treatment by Region (2016-2021)
8.2 Middle East & Africa Metastatic Cancer Treatment Market Size by Type (2016-2021)
8.3 Middle East & Africa Metastatic Cancer Treatment Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Metastatic Cancer Treatment Market Forecast
10.1 Global Metastatic Cancer Treatment Forecast by Regions (2021-2026)
10.1.1 Global Metastatic Cancer Treatment Forecast by Regions (2021-2026)
10.1.2 Americas Metastatic Cancer Treatment Forecast
10.1.3 APAC Metastatic Cancer Treatment Forecast
10.1.4 Europe Metastatic Cancer Treatment Forecast
10.1.5 Middle East & Africa Metastatic Cancer Treatment Forecast
10.2 Americas Metastatic Cancer Treatment Forecast by Countries (2021-2026)
10.2.1 United States Metastatic Cancer Treatment Market Forecast
10.2.2 Canada Metastatic Cancer Treatment Market Forecast
10.2.3 Mexico Metastatic Cancer Treatment Market Forecast
10.2.4 Brazil Metastatic Cancer Treatment Market Forecast
10.3 APAC Metastatic Cancer Treatment Forecast by Region (2021-2026)
10.3.1 China Metastatic Cancer Treatment Market Forecast
10.3.2 Japan Metastatic Cancer Treatment Market Forecast
10.3.3 Korea Metastatic Cancer Treatment Market Forecast
10.3.4 Southeast Asia Metastatic Cancer Treatment Market Forecast
10.3.5 India Metastatic Cancer Treatment Market Forecast
10.3.6 Australia Metastatic Cancer Treatment Market Forecast
10.4 Europe Metastatic Cancer Treatment Forecast by Country (2021-2026)
10.4.1 Germany Metastatic Cancer Treatment Market Forecast
10.4.2 France Metastatic Cancer Treatment Market Forecast
10.4.3 UK Metastatic Cancer Treatment Market Forecast
10.4.4 Italy Metastatic Cancer Treatment Market Forecast
10.4.5 Russia Metastatic Cancer Treatment Market Forecast
10.5 Middle East & Africa Metastatic Cancer Treatment Forecast by Region (2021-2026)
10.5.1 Egypt Metastatic Cancer Treatment Market Forecast
10.5.2 South Africa Metastatic Cancer Treatment Market Forecast
10.5.3 Israel Metastatic Cancer Treatment Market Forecast
10.5.4 Turkey Metastatic Cancer Treatment Market Forecast
10.5.5 GCC Countries Metastatic Cancer Treatment Market Forecast
10.6 Global Metastatic Cancer Treatment Forecast by Type (2021-2026)
10.7 Global Metastatic Cancer Treatment Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Metastatic Cancer Treatment Product Offered
11.1.3 Roche Metastatic Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Metastatic Cancer Treatment Product Offered
11.2.3 Novartis Metastatic Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Merck
11.3.1 Merck Company Information
11.3.2 Merck Metastatic Cancer Treatment Product Offered
11.3.3 Merck Metastatic Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Merck Main Business Overview
11.3.5 Merck Latest Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Company Information
11.4.2 Eli Lilly Metastatic Cancer Treatment Product Offered
11.4.3 Eli Lilly Metastatic Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Eli Lilly Main Business Overview
11.4.5 Eli Lilly Latest Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Information
11.5.2 Johnson & Johnson Metastatic Cancer Treatment Product Offered
11.5.3 Johnson & Johnson Metastatic Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Johnson & Johnson Main Business Overview
11.5.5 Johnson & Johnson Latest Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Metastatic Cancer Treatment Product Offered
11.6.3 Pfizer Metastatic Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Pfizer Main Business Overview
11.6.5 Pfizer Latest Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Information
11.7.2 AstraZeneca Metastatic Cancer Treatment Product Offered
11.7.3 AstraZeneca Metastatic Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 AstraZeneca Main Business Overview
11.7.5 AstraZeneca Latest Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Information
11.8.2 GlaxoSmithKline Metastatic Cancer Treatment Product Offered
11.8.3 GlaxoSmithKline Metastatic Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 GlaxoSmithKline Main Business Overview
11.8.5 GlaxoSmithKline Latest Developments
11.9 Sun Pharmaceutical
11.9.1 Sun Pharmaceutical Company Information
11.9.2 Sun Pharmaceutical Metastatic Cancer Treatment Product Offered
11.9.3 Sun Pharmaceutical Metastatic Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Sun Pharmaceutical Main Business Overview
11.9.5 Sun Pharmaceutical Latest Developments
11.10 Bayer
11.10.1 Bayer Company Information
11.10.2 Bayer Metastatic Cancer Treatment Product Offered
11.10.3 Bayer Metastatic Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Bayer Main Business Overview
11.10.5 Bayer Latest Developments
11. Gilead Sciences
11.11.1 Gilead Sciences Company Information
11.11.2 Gilead Sciences Metastatic Cancer Treatment Product Offered
11.11.3 Gilead Sciences Metastatic Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Gilead Sciences Main Business Overview
11.11.5 Gilead Sciences Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Metastatic Cancer Treatment Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Chemotherapy
Table 3. Major Players of Radiation Therapy
Table 4. Major Players of Biologic Targeted Therapy
Table 5. Major Players of Hormone Therapy
Table 6. Metastatic Cancer Treatment Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 7. Global Metastatic Cancer Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 8. Global Metastatic Cancer Treatment Market Size Market Share by Type (2016-2021)
Table 9. Metastatic Cancer Treatment Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 10. Global Metastatic Cancer Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 11. Global Metastatic Cancer Treatment Market Size Market Share by Application (2016-2021)
Table 12. Global Metastatic Cancer Treatment Revenue by Players (2019-2021E) & ($ Millions)
Table 13. Global Metastatic Cancer Treatment Revenue Market Share by Players (2019-2021E)
Table 14. Metastatic Cancer Treatment Key Players Head office and Products Offered
Table 15. Metastatic Cancer Treatment Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Metastatic Cancer Treatment Market Size by Regions 2016-2021 & ($ Millions)
Table 19. Global Metastatic Cancer Treatment Market Size Market Share by Regions 2016-2021
Table 20. Americas Metastatic Cancer Treatment Market Size by Country (2016-2021) & ($ Millions)
Table 21. Americas Metastatic Cancer Treatment Market Size Market Share by Country (2016-2021)
Table 22. Americas Metastatic Cancer Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 23. Americas Metastatic Cancer Treatment Market Size Market Share by Type (2016-2021)
Table 24. Americas Metastatic Cancer Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 25. Americas Metastatic Cancer Treatment Market Size Market Share by Application (2016-2021)
Table 26. APAC Metastatic Cancer Treatment Market Size by Region (2016-2021) & ($ Millions)
Table 27. APAC Metastatic Cancer Treatment Market Size Market Share by Region (2016-2021)
Table 28. APAC Metastatic Cancer Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 29. APAC Metastatic Cancer Treatment Market Size Market Share by Type (2016-2021)
Table 30. APAC Metastatic Cancer Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 31. APAC Metastatic Cancer Treatment Market Size Market Share by Application (2016-2021)
Table 32. Europe Metastatic Cancer Treatment Market Size by Country (2016-2021) & ($ Millions)
Table 33. Europe Metastatic Cancer Treatment Market Size Market Share by Country (2016-2021)
Table 34. Europe Metastatic Cancer Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 35. Europe Metastatic Cancer Treatment Market Size Market Share by Type (2016-2021)
Table 36. Europe Metastatic Cancer Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 37. Europe Metastatic Cancer Treatment Market Size Market Share by Application (2016-2021)
Table 38. Middle East & Africa Metastatic Cancer Treatment Market Size by Region (2016-2021) & ($ Millions)
Table 39. Middle East & Africa Metastatic Cancer Treatment Market Size Market Share by Region (2016-2021)
Table 40. Middle East & Africa Metastatic Cancer Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 41. Middle East & Africa Metastatic Cancer Treatment Market Size Market Share by Type (2016-2021)
Table 42. Middle East & Africa Metastatic Cancer Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 43. Middle East & Africa Metastatic Cancer Treatment Market Size Market Share by Application (2016-2021)
Table 44. Key and Potential Regions of Metastatic Cancer Treatment
Table 45. Key Application and Potential Industries of Metastatic Cancer Treatment
Table 46. Key Challenges of Metastatic Cancer Treatment
Table 47. Key Trends of Metastatic Cancer Treatment
Table 48. Global Metastatic Cancer Treatment Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 49. Global Metastatic Cancer Treatment Market Size Market Share Forecast by Regions (2021-2026)
Table 50. Global Metastatic Cancer Treatment Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 51. Global Metastatic Cancer Treatment Market Size Market Share Forecast by Type (2021-2026)
Table 52. Global Metastatic Cancer Treatment Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 53. Global Metastatic Cancer Treatment Market Size Market Share Forecast by Application (2021-2026)
Table 54. Roche Details, Company Type, Metastatic Cancer Treatment Area Served and Its Competitors
Table 55. Roche Metastatic Cancer Treatment Product Offered
Table 56. Roche Metastatic Cancer Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 57. Roche Main Business
Table 58. Roche Latest Developments
Table 59. Novartis Details, Company Type, Metastatic Cancer Treatment Area Served and Its Competitors
Table 60. Novartis Metastatic Cancer Treatment Product Offered
Table 61. Novartis Main Business
Table 62. Novartis Metastatic Cancer Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 63. Novartis Latest Developments
Table 64. Merck Details, Company Type, Metastatic Cancer Treatment Area Served and Its Competitors
Table 65. Merck Metastatic Cancer Treatment Product Offered
Table 66. Merck Main Business
Table 67. Merck Metastatic Cancer Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 68. Merck Latest Developments
Table 69. Eli Lilly Details, Company Type, Metastatic Cancer Treatment Area Served and Its Competitors
Table 70. Eli Lilly Metastatic Cancer Treatment Product Offered
Table 71. Eli Lilly Main Business
Table 72. Eli Lilly Metastatic Cancer Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 73. Eli Lilly Latest Developments
Table 74. Johnson & Johnson Details, Company Type, Metastatic Cancer Treatment Area Served and Its Competitors
Table 75. Johnson & Johnson Metastatic Cancer Treatment Product Offered
Table 76. Johnson & Johnson Main Business
Table 77. Johnson & Johnson Metastatic Cancer Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 78. Johnson & Johnson Latest Developments
Table 79. Pfizer Details, Company Type, Metastatic Cancer Treatment Area Served and Its Competitors
Table 80. Pfizer Metastatic Cancer Treatment Product Offered
Table 81. Pfizer Main Business
Table 82. Pfizer Metastatic Cancer Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 83. Pfizer Latest Developments
Table 84. AstraZeneca Details, Company Type, Metastatic Cancer Treatment Area Served and Its Competitors
Table 85. AstraZeneca Metastatic Cancer Treatment Product Offered
Table 86. AstraZeneca Main Business
Table 87. AstraZeneca Metastatic Cancer Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 88. AstraZeneca Latest Developments
Table 89. GlaxoSmithKline Details, Company Type, Metastatic Cancer Treatment Area Served and Its Competitors
Table 90. GlaxoSmithKline Metastatic Cancer Treatment Product Offered
Table 91. GlaxoSmithKline Main Business
Table 92. GlaxoSmithKline Metastatic Cancer Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 93. GlaxoSmithKline Latest Developments
Table 94. Sun Pharmaceutical Details, Company Type, Metastatic Cancer Treatment Area Served and Its Competitors
Table 95. Sun Pharmaceutical Metastatic Cancer Treatment Product Offered
Table 96. Sun Pharmaceutical Main Business
Table 97. Sun Pharmaceutical Metastatic Cancer Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 98. Sun Pharmaceutical Latest Developments
Table 99. Bayer Details, Company Type, Metastatic Cancer Treatment Area Served and Its Competitors
Table 100. Bayer Metastatic Cancer Treatment Product Offered
Table 101. Bayer Main Business
Table 102. Bayer Metastatic Cancer Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 103. Bayer Latest Developments
Table 104. Gilead Sciences Details, Company Type, Metastatic Cancer Treatment Area Served and Its Competitors
Table 105. Gilead Sciences Metastatic Cancer Treatment Product Offered
Table 106. Gilead Sciences Metastatic Cancer Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 107. Gilead Sciences Main Business
Table 108. Gilead Sciences Latest Developments
List of Figures
Figure 1. Metastatic Cancer Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Metastatic Cancer Treatment Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Metastatic Cancer Treatment Market Size Market Share by Type in 2020
Figure 7. Metastatic Cancer Treatment in Hospitals
Figure 8. Global Metastatic Cancer Treatment Market: Hospitals (2016-2021) & ($ Millions)
Figure 9. Metastatic Cancer Treatment in Clinics
Figure 10. Global Metastatic Cancer Treatment Market: Clinics (2016-2021) & ($ Millions)
Figure 11. Metastatic Cancer Treatment in Other
Figure 12. Global Metastatic Cancer Treatment Market: Other (2016-2021) & ($ Millions)
Figure 13. Global Metastatic Cancer Treatment Market Size Market Share by Application in 2020
Figure 14. Global Metastatic Cancer Treatment Revenue Market Share by Player in 2020
Figure 15. Global Metastatic Cancer Treatment Market Size Market Share by Regions (2016-2021)
Figure 16. Americas Metastatic Cancer Treatment Market Size 2016-2021 ($ Millions)
Figure 17. APAC Metastatic Cancer Treatment Market Size 2016-2021 ($ Millions)
Figure 18. Europe Metastatic Cancer Treatment Market Size 2016-2021 ($ Millions)
Figure 19. Middle East & Africa Metastatic Cancer Treatment Market Size 2016-2021 ($ Millions)
Figure 20. Americas Metastatic Cancer Treatment Market Size Market Share by Country in 2020
Figure 21. Americas Metastatic Cancer Treatment Market Size Market Share by Type in 2020
Figure 22. Americas Metastatic Cancer Treatment Market Size Market Share by Application in 2020
Figure 23. United States Metastatic Cancer Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 24. Canada Metastatic Cancer Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 25. Mexico Metastatic Cancer Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 26. APAC Metastatic Cancer Treatment Market Size Market Share by Regions in 2020
Figure 27. APAC Metastatic Cancer Treatment Market Size Market Share by Type in 2020
Figure 28. APAC Metastatic Cancer Treatment Market Size Market Share by Application in 2020
Figure 29. China Metastatic Cancer Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 30. Japan Metastatic Cancer Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 31. Korea Metastatic Cancer Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 32. Southeast Asia Metastatic Cancer Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 33. India Metastatic Cancer Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 34. Australia Metastatic Cancer Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 35. Europe Metastatic Cancer Treatment Market Size Market Share by Country in 2020
Figure 36. Europe Metastatic Cancer Treatment Market Size Market Share by Type in 2020
Figure 37. Europe Metastatic Cancer Treatment Market Size Market Share by Application in 2020
Figure 38. Germany Metastatic Cancer Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 39. France Metastatic Cancer Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 40. UK Metastatic Cancer Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 41. Italy Metastatic Cancer Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 42. Russia Metastatic Cancer Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 43. Middle East & Africa Metastatic Cancer Treatment Market Size Market Share by Region in 2020
Figure 44. Middle East & Africa Metastatic Cancer Treatment Market Size Market Share by Type in 2020
Figure 45. Middle East & Africa Metastatic Cancer Treatment Market Size Market Share by Application in 2020
Figure 46. Egypt Metastatic Cancer Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 47. South Africa Metastatic Cancer Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 48. Israel Metastatic Cancer Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 49. Turkey Metastatic Cancer Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 50. GCC Country Metastatic Cancer Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 51. Americas Metastatic Cancer Treatment Market Size 2021-2026 ($ Millions)
Figure 52. APAC Metastatic Cancer Treatment Market Size 2021-2026 ($ Millions)
Figure 53. Europe Metastatic Cancer Treatment Market Size 2021-2026 ($ Millions)
Figure 54. Middle East & Africa Metastatic Cancer Treatment Market Size 2021-2026 ($ Millions)
Figure 55. United States Metastatic Cancer Treatment Market Size 2021-2026 ($ Millions)
Figure 56. Canada Metastatic Cancer Treatment Market Size 2021-2026 ($ Millions)
Figure 57. Mexico Metastatic Cancer Treatment Market Size 2021-2026 ($ Millions)
Figure 58. Brazil Metastatic Cancer Treatment Market Size 2021-2026 ($ Millions)
Figure 59. China Metastatic Cancer Treatment Market Size 2021-2026 ($ Millions)
Figure 60. Japan Metastatic Cancer Treatment Market Size 2021-2026 ($ Millions)
Figure 61. Korea Metastatic Cancer Treatment Market Size 2021-2026 ($ Millions)
Figure 62. Southeast Asia Metastatic Cancer Treatment Market Size 2021-2026 ($ Millions)
Figure 63. India Metastatic Cancer Treatment Market Size 2021-2026 ($ Millions)
Figure 64. Australia Metastatic Cancer Treatment Market Size 2021-2026 ($ Millions)
Figure 65. Germany Metastatic Cancer Treatment Market Size 2021-2026 ($ Millions)
Figure 66. France Metastatic Cancer Treatment Market Size 2021-2026 ($ Millions)
Figure 67. UK Metastatic Cancer Treatment Market Size 2021-2026 ($ Millions)
Figure 68. Italy Metastatic Cancer Treatment Market Size 2021-2026 ($ Millions)
Figure 69. Russia Metastatic Cancer Treatment Market Size 2021-2026 ($ Millions)
Figure 70. Spain Metastatic Cancer Treatment Market Size 2021-2026 ($ Millions)
Figure 71. Egypt Metastatic Cancer Treatment Market Size 2021-2026 ($ Millions)
Figure 72. South Africa Metastatic Cancer Treatment Market Size 2021-2026 ($ Millions)
Figure 73. Israel Metastatic Cancer Treatment Market Size 2021-2026 ($ Millions)
Figure 74. Turkey Metastatic Cancer Treatment Market Size 2021-2026 ($ Millions)
Figure 75. GCC Country Metastatic Cancer Treatment Market Size 2021-2026 ($ Millions)

※본 조사보고서 [세계의 전이성 암 치료 시장예측 2021년-2026년] (코드 : LPI-2201K02228) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 전이성 암 치료 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 전이성 흑색종 진단 시장예측 2021년-2026년
LPI-2201K03870 / LP Information / 2021년 12월 / 본 조사보고서는 전이성 흑색종 진단의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Metastatic Melanoma Diagnostic will have significant change from previous year. By the most conservative estimates of global Metastatic Melanoma Diagnostic market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 구강암 치료 시장예측 2021년-2026년
LPI-2201K02096 / LP Information / 2021년 12월 / 본 조사보고서는 구강암 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Mouth Cancer Treatment will have significant change from previous year. By the most conservative estimates of global Mouth Cancer Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 HER2-음성 유방암 치료 시장예측 2021년-2026년
LPI-2201K00124 / LP Information / 2021년 12월 / 본 조사보고서는 HER2-음성 유방암 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of HER2-negative Breast Cancer Treatment will have significant change from previous year. By the most conservative estimates of global HER2-negative Breast Cancer Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...

세계의 호르몬 불응성 전립선암 시장예측 2021년-2026년
LPI-2201K00131 / LP Information / 2021년 12월 / 본 조사보고서는 호르몬 불응성 전립선암의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Hormone Refractory Prostate Cancer will have significant change from previous year. By the most conservative estimates of global Hormone Refractory Prostate Cancer market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...

세계의 과민성 방광 치료 시장예측 2021년-2026년
LPI-2201K02444 / LP Information / 2021년 12월 / 본 조사보고서는 과민성 방광 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Overactive Bladder Treatment will have significant change from previous year. By the most conservative estimates of global Overactive Bladder Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 4901 million in...

세계의 패혈증 치료 시장예측 2021년-2026년
LPI-2201K02174 / LP Information / 2021년 12월 / 본 조사보고서는 패혈증 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Sepsis Treatment will have significant change from previous year. By the most conservative estimates of global Sepsis Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 3072.3 million in 2020. Over...